Lifeway Foods, Inc. (LWAY) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025. Lifeway Foods, Inc. is the largest producer and marketer of kefir in the United States, operating as a single reportable segment. The company manufactures and distributes cultured dairy products, including drinkable kefir, European-style soft cheeses, and drinkable yogurt, primarily through retail and distributor channels in the U.S.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $53.90 million | $49.16 million | $99.99 million | $93.79 million |
| Gross Profit | $15.40 million | $13.28 million | $26.44 million | $24.81 million |
| Gross Margin | 28.6% | 27.0% | 26.5% | 26.4% |
| Operating Income | $5.80 million | $5.39 million | $7.37 million | $8.95 million |
| Net Income | $4.25 million | $3.78 million | $7.79 million | $6.21 million |
| Diluted EPS | $0.28 | $0.25 | $0.51 | $0.41 |
| Cash & Equivalents | $21.22 million (as of June 30, 2025) | |||
| Operating Cash Flow (YTD) | $3.76 million (2025) vs $8.09 million (2024) | |||
| Debt Outstanding | $0 (Revolving Credit Facility: $25.0 million available) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.7% in Q2 and 6.6% YTD compared to the prior year. Management notes that on a comparable basis (adjusting for a strategically exited customer and a distributor logistics shift in 2024), sales increased approximately 18% in Q2 and 14% YTD.
- Margin Expansion: Gross margin improved to 28.6% in Q2 from 27.0% in Q2 2024, driven by manufacturing efficiencies from higher volumes and favorable conventional milk pricing, partially offset by higher organic milk costs.
- Operating Expenses: Selling expenses rose significantly (32% in Q2) due to increased marketing investments. General and administrative expenses increased due to professional fees related to non-routine stockholder actions and an unsolicited purchase proposal from Danone.
- Investment Activity: The company liquidated its equity investment in Simple Mills in February 2025, recognizing a gain of $3.41 million in the first half of 2025. This contributed to a net cash inflow from investing activities of $0.80 million YTD, compared to an outflow of $3.91 million in the prior year.
Outlook, Risks, and Unusual Items
- Supply Chain Strategy: To secure organic milk supply, the company purchased 224 mature dairy cows in July 2025 for $0.69 million and entered a 39-month agreement with a third-party dairy facility to manage the herd. The accounting treatment for this transaction is currently being assessed.
- Debt Facility: In February 2025, the company increased its revolving credit facility commitment from $5.0 million to $25.0 million and extended the maturity to 2028. The company remains in compliance with all covenants.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) was enacted on July 4, 2025. Management does not currently expect a material impact on the estimated annual effective tax rate or cash flows for the current fiscal year.
- Risks: Key risks include commodity price volatility (specifically organic milk), supply chain disruptions, and the impact of macroeconomic conditions on consumer spending. The company also faces potential risks related to the unsolicited purchase proposal from Danone.
Investor Verification Checklist
- Verify the sustainability of the 18% comparable sales growth rate cited by management after adjusting for one-time customer and distributor changes.
- Monitor the impact of rising organic milk prices on future gross margins, as this was a noted offset to efficiency gains.
- Review the final accounting treatment for the July 2025 dairy herd purchase and the associated third-party management agreement.
- Assess the long-term impact of the increased selling expense ratio (9.4% YTD) on operating leverage.
- Confirm the status of the Danone unsolicited purchase proposal and any associated professional fees impacting G&A expenses.